Invesaro

Stocks LSTA Earnings

Earnings

Lisata Therapeutics, Inc. (LSTA) earnings

Quarterly results of Lisata Therapeutics, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.

Free, no password. An email when LSTA files with the SEC.

Next earnings date

Lisata Therapeutics, Inc. was expected to report around October 19, 2026; nothing is on file with the SEC yet.

Latest quarter: Q2 FY2025

In Q2 FY2025 (ended June 30, 2026) Lisata Therapeutics, Inc. reported revenue of $0 and a net loss of $2.9M.

Diluted earnings per share were -$0.32.

Filed with the SEC on August 6, 2026.

Revenue by quarter
Q3 24: $0 $0 Q3 24Q4 24: $1M $1M Q4 24Q1 24: $0 $0 Q1 24Q2 24: $70K $70K Q2 24Q3 24: $0 $0 Q3 24Q4 24: $100K $100K Q4 24Q1 25: $0 $0 Q1 25Q2 25: $0 $0 Q2 25
Net income by quarter
Q3 24: -$4.9M -$4.9M Q3 24Q4 24: -$4.6M -$4.6M Q4 24Q1 24: -$4.7M -$4.7M Q1 24Q2 24: -$4.7M -$4.7M Q2 24Q3 24: -$4.2M -$4.2M Q3 24Q4 24: -$3M -$3M Q4 24Q1 25: -$4.5M -$4.5M Q1 25Q2 25: -$2.9M -$2.9M Q2 25

Quarter by quarter

QuarterEndedRevenuevs year agoNet incomeEPS
Q2 FY2025June 30, 2026$0--$2.9M-$0.32
Q1 FY2025March 31, 2026$0--$4.5M-$0.50
Q4 FY2024December 31, 2025$100K--$3M-
Q3 FY2024September 30, 2025$0--$4.2M-$0.49
Q2 FY2024June 30, 2025$70K--$4.7M-$0.54
Q1 FY2024March 31, 2025$0--$4.7M-$0.55
Q4 FY2024December 31, 2024$1M--$4.6M-
Q3 FY2024September 30, 2024$0--$4.9M-$0.59

Fourth quarters are the fiscal year minus the first three, as most companies report no separate Q4 figures.

Results filings

When is Lisata Therapeutics, Inc.'s next earnings date?

Lisata Therapeutics, Inc. was expected to report around October 19, 2026; nothing is on file with the SEC yet.

What were Lisata Therapeutics, Inc.'s latest quarterly results?

For Q2 FY2025, which ended June 30, 2026, Lisata Therapeutics, Inc. reported revenue of $0 and a net loss of $2.9M. The figures come from its filing with the SEC.

Get an email when LSTA reports

Follow LSTA and we email you its next results the day they are filed, with the numbers explained.

Free, no password. An email when LSTA files with the SEC.

Source: quarterly figures Lisata Therapeutics, Inc. tags in its 10-Q and 10-K filings (SEC EDGAR XBRL). Not investment advice.

Everything about Lisata Therapeutics, Inc.